673 — China Health Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$421.52m
- HK$430.14m
- HK$76.41m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -19.9 | -34.3 | -5.33 | -8.71 | -39.4 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -0.443 | 19.9 | -4.43 | -1.72 | 27.2 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.39 | -10.4 | -2.81 | 38.3 | -0.175 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -17.3 | -22.3 | -9 | 31.9 | -8.22 |
Capital Expenditures | 0 | -0.427 | -1.84 | -0.795 | -2 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.534 | -1.84 | 0.008 | -34.5 | -3.4 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.534 | -2.27 | -1.83 | -35.3 | -5.4 |
Financing Cash Flow Items | 1.56 | 1.09 | -0.07 | -0.153 | -0.449 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 6.96 | 4.98 | 2.56 | 12.8 | 27.7 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -9.06 | -19.7 | -5.65 | 3.94 | 2.94 |